SchaeffersResearch.com5h
2 Healthcare Stocks in Focus After Merger Talks Break Down
Since the start of the year, Humana stock is underperforming with a 39.4% deficit. The $300 level, which provided support ...
Cautious Optimism: Humana’s Hold Rating Amid Market Challenges and Strategic Adjustments
Humana (HUM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst on November 7. Analyst Whit Mayo ...
Cigna Group Confirms It Isn't Looking to Acquire Humana
Late last year, The Wall Street Journal reported that Cigna was in talks with Humana for a healthcare merger but abandoned its pursuit after shareholders balked at a deal that would have created a ...
Humana Q3 Earnings Review: The Medicare Advantage Madness May Finally Be Over
Humana's stock has fallen over 30% due to rising healthcare utilization and CMS pushing back on insurer profits, impacting MA ...
Humana upgraded to Neutral at BofA after Trump win
As previously reported, BofA upgraded Humana (HUM) to Neutral from Underperform with a price target of $308, up from $247, on the results of ...
The American Journal of Managed Care5d
Cigna-Humana Resume Megamerger Talks: Impact on Stakeholders, Health Outcomes, and Cost
As Cigna and Humana pick back up on the potential for a megamerger, executives will be keeping a close eye on the outcomes of ...
Stocktwits on MSN4d
US Election 2024: BoFA Securities Revamps Ratings On Humana, UHS, Ardent, Oscar Health Stocks After Trump Win
Securities updated its ratings on several healthcare stocks, according to thefly.com, indicating a mixed outlook for the ...
MarketWatch5d
Humana Inc. stock outperforms competitors on strong trading day
Shares of Humana Inc. HUM rose 1.98% to $260.60 Tuesday, on what proved to be an all-around favorable trading session for ...